日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registry

疑似系统性硬化症相关肺动脉高压患者的一氧化碳肺弥散量、一氧化碳肺转运系数和用力肺活量/一氧化碳肺弥散量:来自 ASPIRE 注册研究的启示

Smith, Howard; Thompson, A A Roger; Akil, Mohammed; Alabed, Samer; Billings, Catherine; Charalampopoulos, Athanasios; Dwivedi, Krit; Elliot, Charlie A; Hameed, Abdul; Haque, Ashraful; Hamilton, Neil; Hill, Catherine; Hurdman, Judith; Kilding, Rachael; Kuet, Kar-Ping; Rajaram, Smitha; Rothman, Alexander M K; Smith, Ian; Swift, Andrew J; Kiely, David G; Condliffe, Robin

Clinical Utility of the PHQ-2 and GAD-2 in Pulmonary Hypertension

PHQ-2 和 GAD-2 在肺动脉高压中的临床应用

Rawlings, Gregg H; Green, Jemma L; Rothman, Alexander M K; Barrell-Stark, Abbie S L; Thompson, Andrew R; Armstrong, Iain

Digital Data Collection Reduces Terminal Digit Bias in Haemodynamic and Physical Activity Measures in Pulmonary Arterial Hypertension

数字化数据采集可减少肺动脉高压患者血流动力学和体力活动指标中的末位数字偏差

Rothman, Alexander M K; Paula-Ribeiro, Marcelle; McNally, Eleanor; Wason, James; Toshner, Mark

Therapeutic potential of allosteric HECT E3 ligase inhibition.

变构 HECT E3 连接酶抑制的治疗潜力

Rothman Alexander M K, Florentin Amir, Zink Florence, Quigley Catherine, Bonneau Olivier, Hemmig Rene, Hachey Amanda, Rejtar Tomas, Thaker Maulik, Jain Rishi, Huang Shih-Min, Sutton Daniel, Roger Jan, Zhang Ji-Hu, Weiler Sven, Cotesta Simona, Ottl Johannes, Srivastava Salil, Kordonsky Alina, Avishid Reut, Yariv Elon, Rathi Ritu, Khvalevsky Oshrit, Troxler Thomas, Binmahfooz Sarah K, Kleifeld Oded, Morrell Nicholas W, Humbert Marc, Thomas Matthew J, Jarai Gabor, Beckwith Rohan E J, Cobb Jennifer S, Smith Nichola, Ostermann Nils, Tallarico John, Shaw Duncan, Guth-Gundel Sabine, Prag Gali, Rowlands David J

Reply to Ding et al.: Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment

回复丁等人:伊马替尼:一种有望治疗肺动脉高压的药物

Rothman, Alexander M K; Villar, Sofia; Law, Martin; Wilkins, Martin R

Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study

伊马替尼在肺动脉高压治疗中的定位:一项剂量探索性 II 期研究

Rothman, Alexander M K; Villar, Sofia S; Middleton, Jennifer; Roussakis, Andreas A; Varian, Frances; Zafar, Hamza; Law, Martin; Apperley, Jane; Bartelink, Imke H; Said, Medhat M; Delgado-SanMartin, Juan A; Kiely, David G; Howard, Luke; Toshner, Mark; Wort, S John; Wilkins, Martin R

Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework

肺动脉高压临床试验中患者报告结局指标的选择:系统评价、荟萃分析和健康相关生活质量框架

Varian, Frances; Burney, Rebecca; Pearson, Charlotte; Goh, Ze Ming; Newman, Joseph; Rawlings, Gregg; Zafar, Hamza; Kiely, David G; Thompson, A A Roger; Condliffe, Robin; Toshner, Mark; McCormack, Ciara; Armstrong, Iain; Peasgood, Tessa; Carlton, Jill; Rothman, Alexander M K

Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?

慢性血栓栓塞性肺动脉高压的血流动力学定义能否区分慢性血栓栓塞性肺病的不同表型?

Cerrone, Ellis; Hameed, Abdul G; Kiely, David G; Condliffe, Robin; Swift, Andrew J; Rajaram, Smitha; Smith, Ian; Hurdman, Judith A; Elliot, Charlie A; Thompson, A A Roger; Rothman, Alexander M K; Charalampopoulos, Athanasios

Development of a Novel, Pulmonary Endovascular Device to Treat Patients With Pulmonary Hypertension

开发一种新型肺血管内装置以治疗肺动脉高压患者

Vollmers, Karl; Scandurra, John; Woolley, Joshua R; Giridharan, Guruprasad A; Rothman, Alexander M K; Pritzker, Marc; Weir, E Kenneth; Gerges, Christian; Lang, Irene

Drug Development for Pulmonary Arterial Hypertension: Unleashing the Potential of Single-Patient Studies Using Continuous Monitoring

肺动脉高压药物研发:利用连续监测释放单患者研究的潜力

Wilkins, Martin R; Villar, Sofia S; Wason, James; Toshner, Mark; Rothman, Alexander M K